Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Nazar Shokun"'
Autor:
Olga Novosad, Irina Kriachok, Tymur Rudiuk, Ian Pastushenko, Iryna Tytorenko, Olena Aleksik, Natalia Shudrak, Tetiana Kadnikova, Olexandr Horbach, Ulyana Melnyk, Larysa Mykhalska, Yana Stepanishyna, Nazar Shokun
Publikováno v:
HemaSphere, Vol 7, p e63006c0 (2023)
Externí odkaz:
https://doaj.org/article/35673a83a1a548bdbac1d68fa60210c0
Autor:
Kateryna Filonenko, Agata Szymańska, Yana Stepanishyna, Nazar Shokun, Tetiana Skrypets, Massimo Federico, Irina Kryachok, Martina Manni, Jan Zaucha
Publikováno v:
HemaSphere, Vol 7, p e8467534 (2023)
Externí odkaz:
https://doaj.org/article/9055163f27554222aca032f156084065
Autor:
Iryna Kriachok, Yana Stepanishyna, Tetiana Skrypets, Nazar Shokun, Arina Martynchyk, Iryna Tytorenko, Olena Aleksik, Mykhailo Krotevych, Martina Manni, Massimo Federico
Publikováno v:
Hematological oncologyREFERENCES.
The Ukrainian Lymphoma Registry (ULR) was established in 2019 with the aim of monitoring the quality of diagnosis, staging, and treatment of lymphoma in Ukraine. Between September 2019 and October 2021, 546 patients with newly diagnosed lymphoma were
Autor:
Yana Stepanishyna, Iryna Kriachok, Nazar Shokun, Nataliia Shapovalenko, Anisiia Luchkiv, Tetiana Skrypets, Martina Manni, Massimo Federico
Publikováno v:
Blood. 140:9525-9525
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S255
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S431
Background Pomalidomide, a new non-chemotherapy drug, has improved the overall and progression-free survival for myeloma patients. We present our first Ukrainian study of pomalidomide usage that showed good results in relapse/refractory (R/R) patient